References
- Baggiolini M. Chemokines in pathology and medicine. J Intern Med. 2001;250:91–15. doi:https://doi.org/10.1046/j.1365-2796.2001.00867.x.
- Mackay CR. Chemokines: immunology’s high impact factors. Nat Immunol. 2001;2:95–101. doi:https://doi.org/10.1038/84298.
- Farooq SM, Stillie R, Svensson M, Svanborg C, Strieter RM, Stadnyk AW. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis. J Pharmacol Exp Ther. 2009;329:123–29. doi:https://doi.org/10.1124/jpet.108.145862.
- Liston A, Kohler RE, Townley S, Haylock-Jacobs S, Comerford I, Caon AC, Webster J, Harrison JM, Swann J, Clark-Lewis I, et al. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. J Immunol. 2009;182:3121–30. doi:https://doi.org/10.4049/jimmunol.0713169.
- Min SH, Wang Y, Gonsiorek W, Anilkumar G, Kozlowski J, Lundell D, Fine JS, Grant EP. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis. Biochem Biophys Res Commun. 2010;391:1080–86. doi:https://doi.org/10.1016/j.bbrc.2009.12.025.
- Mackay CR. Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat Immunol. 2008;9:988–98. doi:https://doi.org/10.1038/ni.f.210.
- Dai Z, Xing L, Cerise J, Wang EH, Jabbari A, de Jong A, Petukhova L, Christiano AM, Clynes R. CXCR3 blockade inhibits T cell migration into the skin and prevents development of Alopecia Areata. J Immunol. 2016;197:1089–99. doi:https://doi.org/10.4049/jimmunol.1501798.
- Chiang EY, Kolumam GA, Yu X, Francesco M, Ivelja S, Peng I, Gribling P, Shu J, Lee WP, Refino CJ, et al. Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease. Nat Med. 2009;15:766–73. doi:https://doi.org/10.1038/nm.1984.
- Robert R, Ang C, Sun G, Juglair L, Lim EX, Mason LJ, Bernard CC, Mackay CR. Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice. JCI Insight. 2017;2(15):e94821. doi: https://doi.org/10.1172/jci.insight.94821.
- Boppana NB, Devarajan A, Gopal K, Barathan M, Bakar SA, Shankar EM, Ebrahim AS, Farooq SM. Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases. Exp Biol Med (Maywood). 2014;239:509–18. doi:https://doi.org/10.1177/1535370213520110.
- Chapman RW, Minnicozzi M, Celly CS, Phillips JE, Kung TT, Hipkin RW, Fan X, Rindgen D, Deno G, Bond R, et al. A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation. J Pharmacol Exp Ther. 2007;322(2):486–93. doi:https://doi.org/10.1124/jpet.106.119040.
- Holz O, Khalilieh S, Ludwig-Sengpiel A, Watz H, Stryszak P, Soni P, Tsai M, Sadeh J, Magnussen H. SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects. Eur Respir J. 2010;35(3):564–70. doi:https://doi.org/10.1183/09031936.00048509.
- Matzer SP, Zombou J, Sarau HM, Rollinghoff M, Beuscher HU. A synthetic, non-peptide CXCR2 antagonist blocks MIP-2-induced neutrophil migration in mice. Immunobiology. 2004;209(3):225–33. doi:https://doi.org/10.1016/j.imbio.2004.02.009.
- Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, Lee DM. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med. 2006;203:837–42. doi:https://doi.org/10.1084/jem.20052371.
- Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol. 2001;167:1601–08. doi:https://doi.org/10.4049/jimmunol.167.3.1601.
- Wang J. Neutrophils in tissue injury and repair. Cell Tissue Res. 2018;371:531–39. doi:https://doi.org/10.1007/s00441-017-2785-7.
- Wilgus TA, Roy S, McDaniel JC. Neutrophils and wound repair: positive actions and negative reactions. Adv Wound Care (New Rochelle). 2013;2:379–88. doi:https://doi.org/10.1089/wound.2012.0383.
- Hosoki K, Rajarathnam K, Sur S. Attenuation of murine allergic airway inflammation with a CXCR1/CXCR2 chemokine receptor inhibitor. Clin Exp Allergy. 2019;49:130–32.
- Lerner CA, Lei W, Sundar IK, Rahman I. Genetic ablation of CXCR2 protects against cigarette smoke-induced lung inflammation and injury. Front Pharmacol. 2016;7:391. doi:https://doi.org/10.3389/fphar.2016.00391.
- Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood W, Moore M. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science. 1994;265:682–84. doi:https://doi.org/10.1126/science.8036519.
- Reutershan J, Morris MA, Burcin TL, Smith DF, Chang D, Saprito MS. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J Clin Invest. 2006;116:695–702. doi:https://doi.org/10.1172/JCI27009.
- Cattani F, Gallese A, Mosca M, Buanne P, Biordi L, Francavilla S, Coletti G, Pellegrini L, Melillo G, Bertini R. The role of CXCR2 activity in the contact hypersensitivity response in mice. Eur Cytokine Netw. 2006;17:42–48.
- Devalaraja RM, Nanney LB, Du J, Qian Q, Yu Y, Devalaraja MN, Richmond A. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol. 2000;115:234–44. doi:https://doi.org/10.1046/j.1523-1747.2000.00034.x.
- Dainichi T, Kitoh A, Otsuka A, Nakajima S, Nomura T, Kaplan DH, Kabashima K. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat Immunol. 2018;19:1286–98. doi:https://doi.org/10.1038/s41590-018-0256-2.
- Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387:1109–22. doi:https://doi.org/10.1016/S0140-6736(15)00149-X.
- Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis–part I: clinical and pathologic concepts. J Allergy Clin Immunol. 2011;127:1110–18. doi:https://doi.org/10.1016/j.jaci.2011.01.053.
- Choy DF, Hsu DK, Seshasayee D, Fung MA, Modrusan Z, Martin F, Liu F-T, Arron JR. Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation. J Allergy Clin Immunol. 2012;130:1335–43 e5. doi:https://doi.org/10.1016/j.jaci.2012.06.044.
- Kueh AJ, Pal M, Tai L, Liao Y, Smyth GK, Shi W, Herold MJ. An update on using CRISPR/Cas9 in the one-cell stage mouse embryo for generating complex mutant alleles. Cell Death Differ. 2017;24:1821–22. doi:https://doi.org/10.1038/cdd.2017.122.
- Robert R, Streltsov VA, Newman J, Pearce LA, Wark KL, Dolezal O. Germline humanization of a murine Abeta antibody and crystal structure of the humanized recombinant Fab fragment. Protein Sci. 2010;19:299–308. doi:https://doi.org/10.1002/pro.312.
- Giudicelli V, Chaume D, Lefranc MP. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 2004;32:W435–40. doi:https://doi.org/10.1093/nar/gkh412.
- Yousfi Monod M, Giudicelli V, Chaume D, Lefranc MP. IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics. 2004;20(Suppl 1):i379–85. doi:https://doi.org/10.1093/bioinformatics/bth945.
- Lee H, Zahra D, Vogelzang A, Newton R, Thatcher J, Quan A, So T, Zwirner J, Koentgen F, Padkjær SB, et al. Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies. Nat Biotechnol. 2006;24:1279–84. doi:https://doi.org/10.1038/nbt1248.
- Akitsu A, Ishigame H, Kakuta S, Chung SH, Ikeda S, Shimizu K, Kubo S, Liu Y, Umemura M, Matsuzaki G, et al. IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2(+)Vgamma6(+)gammadelta T cells. Nat Commun. 2015;6:7464. doi:https://doi.org/10.1038/ncomms8464.
- Mihara K, Smit MJ, Krajnc-Franken M, Gossen J, Rooseboom M, Dokter W. Human CXCR2 (hCXCR2) takes over functionalities of its murine homolog in hCXCR2 knockin mice. Eur J Immunol. 2005;35:2573–82. doi:https://doi.org/10.1002/eji.200526021.
- Wu L, Ruffing N, Shi X, Newman W, Soler D, Mackay CR, Qin S. Discrete steps in binding and signaling of interleukin-8 with its receptor. J Biol Chem. 1996;271:31202–09. doi:https://doi.org/10.1074/jbc.271.49.31202.
- Rossant CJ, Carroll D, Huang L, Elvin J, Neal F, Walker E, Benschop JJ, Kim EE, Barry ST, Vaughan TJ, et al. Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes. MAbs. 2014;6:1425–38. doi:https://doi.org/10.4161/mabs.34376.
- Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, Hepworth MR, Van Voorhees AS, Comeau MR, Artis D, et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med. 2013;5:170ra16. doi:https://doi.org/10.1126/scitranslmed.3005374.
- Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U S A. 2006;103:11736–41. doi:https://doi.org/10.1073/pnas.0604575103.
- Naidoo K, Jagot F, van den Elsen L, Pellefigues C, Jones A, Luo H, Johnston K, Painter G, Roediger B, Lee J, et al. Eosinophils determine dermal thickening and water loss in an MC903 model of atopic dermatitis. J Invest Dermatol. 2018;138:2606–16. doi:https://doi.org/10.1016/j.jid.2018.06.168.
- Walsh CM, Hill RZ, Schwendinger-Schreck J, Deguine J, Brock EC, Kucirek N, Rifi Z ,Wei J, Gronert K, Brem RB, et al. Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis. Elife. 2019;8:e48448. doi:https://doi.org/10.7554/eLife.48448.
- Liu FT, Goodarzi H, Chen HY. IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol. 2011;41:298–310. doi:https://doi.org/10.1007/s12016-011-8252-4.
- Oyoshi MK, He R, Li Y, Mondal S, Yoon J, Afshar R, Chen M, Lee D, Luo H, Luster A, et al. Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation. Immunity. 2012;37:747–58. doi:https://doi.org/10.1016/j.immuni.2012.06.018.
- Siracusa MC, Kim BS, Spergel JM, Artis D. Basophils and allergic inflammation. J Allergy Clin Immunol. 2013;132:789–801. quiz 788. doi:https://doi.org/10.1016/j.jaci.2013.07.046.
- Chou RC, Kim ND, Sadik CD, Seung E, Lan Y, Byrne MH, Haribabu B, Iwakura Y, Luster AD. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity. 2010;33:266–78. doi:https://doi.org/10.1016/j.immuni.2010.07.018.
- Jacobs JP, Ortiz-Lopez A, Campbell JJ, Gerard CJ, Mathis D, Benoist C. Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum. 2010;62:1921–32.
- Solomon S, Rajasekaran N, Jeisy-Walder E, Snapper SB, Illges H. A crucial role for macrophages in the pathology of K/B x N serum-induced arthritis. Eur J Immunol. 2005;35:3064–73. doi:https://doi.org/10.1002/eji.200526167.
- Lebre MC, Jongbloed SL, Tas SW, Smeets TJ, McInnes IB, Tak PP. Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles. Am J Pathol. 2008;172:940–50. doi:https://doi.org/10.2353/ajpath.2008.070703.
- Thomas R, MacDonald KP, Pettit AR, Cavanagh LL, Padmanabha J, Zehntner S. Dendritic cells and the pathogenesis of rheumatoid arthritis. J Leukoc Biol. 1999;66:286–92. doi:https://doi.org/10.1002/jlb.66.2.286.
- Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 2002;297:1689–92. doi:https://doi.org/10.1126/science.1073176.
- Conigliaro P, Scrivo R, Valesini G, Perricone R. Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. Autoimmun Rev. 2011;10:577–81. doi:https://doi.org/10.1016/j.autrev.2011.04.017.
- Yamin R, Berhani O, Peleg H, Aamar S, Stein N, Gamliel M, Hindi I, Scheiman-Elazary A, Gur C. High percentages and activity of synovial fluid NK cells present in patients with advanced stage active rheumatoid arthritis. Sci Rep. 2019;9:1351. doi:https://doi.org/10.1038/s41598-018-37448-z.
- Blom AB, van Lent PL, van Vuuren H, Holthuysen AE, Jacobs C, van de Putte LB, van de Winkel JG, van den Berg WB. Fc gamma R expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA). Arthritis Res. 2000;2:489–503. doi:https://doi.org/10.1186/ar131.
- Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res. 2000;2:189–202. doi:https://doi.org/10.1186/ar86.
- Campbell IK, Leong D, Edwards KM, Rayzman V, Ng M, Goldberg GL, Wilson NJ, Scalzo-Inguanti K, Mackenzie-Kludas C, Lawlor KE, et al. Therapeutic targeting of the G-CSF receptor reduces neutrophil trafficking and joint inflammation in antibody-mediated inflammatory arthritis. J Immunol. 2016;197:4392–402. doi:https://doi.org/10.4049/jimmunol.1600121.
- Zhang X, Guo R, Kambara H, Ma F, Luo HR. The role of CXCR2 in acute inflammatory responses and its antagonists as anti-inflammatory therapeutics. Curr Opin Hematol. 2019;26:28–33. doi:https://doi.org/10.1097/MOH.0000000000000476.
- Wahlgren CF. Itch and atopic dermatitis: an overview. J Dermatol. 1999;26:770–79. doi:https://doi.org/10.1111/j.1346-8138.1999.tb02090.x.
- Ewald DA, Noda S, Oliva M, Litman T, Nakajima S, Li X, Xu H, Workman CT, Scheipers P, Svitacheva N, et al. Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling. J Allergy Clin Immunol. 2017;139:562–71. doi:https://doi.org/10.1016/j.jaci.2016.08.029.
- Guttman-Yassky E, Suarez-Farinas M, Chiricozzi A, Nograles KE, Shemer A, Fuentes-Duculan J, Cardinale I, Lin P, Bergman R, Bowcock AM, et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol. 2009;124:1235–44 e58. doi:https://doi.org/10.1016/j.jaci.2009.09.031.
- Suarez-Farinas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C, Krueger JG, Guttman-Yassky E. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013;132:361–70. doi:https://doi.org/10.1016/j.jaci.2013.04.046.
- Huang QQ, Birkett R, Doyle R, Shi B, Roberts EL, Mao Q, Pope RM. The role of macrophages in the response to TNF inhibition in experimental arthritis. J Immunol. 2018;200:130–38. doi:https://doi.org/10.4049/jimmunol.1700229.